Bank Of New York Mellon Corp Imago Bio Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $1.5 Million - $3.6 Million	100,126 New	100,126 $3.6 Million
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $199,076 - $274,345	14,069 Added 22.34%	77,034 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$11.81 - $20.92 $133,878 - $237,149	11,336 Added 21.96%	62,965 $843,000
Q1 2022 May 11, 2022	BUY	$16.97 - $25.0 $401,527 - $591,525	23,661 Added 84.6%	51,629 $995,000
Q4 2021 Feb 11, 2022	BUY	$16.22 - $29.69 $59,900 - $109,645	3,693 Added 15.21%	27,968 $664,000
Q3 2021 Nov 12, 2021	BUY	$16.0 - $28.84 $388,400 - $700,091	24,275 New	24,275 $487,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.